Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chirac

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Developpement Et Sante : Revue De Perfectionnement Medical Et Sanitaire En Pays Tropical|January 1, 1989
[At the Savar center, primary health care (PHC) evolves with the health conditions]P Chirac
Transactions of the Royal Society of Tropical Medicine and Hygiene|July 31, 2003
Translating the essential drugs concept into the context of the year 2000P Chirac
The International Journal of Risk & Safety in Medicine|March 21, 2013
Ethics in the pharmaceutical industry: acceptance of responsibility or a facet of marketing?P Chirac
Lancet (London, England)|April 17, 2001
Updating the WHO essential drugs listP Chirac, R Laing
Lancet (London, England)|October 6, 1998
Intellectual property protection and pharmaceuticalsP Chirac, M Kaddar
Social Science & Medicine (1982)|June 1, 1993
Drug marketing in French-speaking African countriesP Chirac, A Pikon, Y Poinsignon, et al.
JAMA|February 3, 1999
Access to essential drugs in poor countries: a lost battle?B Pécoul, P Chirac, P Trouiller, et al.
Lancet (London, England)|January 6, 2001
Access to fluconazole in less-developed countriesC Perez-Casas, P Chirac, D Berman, et al.
Lancet (London, England)|September 12, 2000
AIDS: patent rights versus patient's rightsP Chirac, T von Schoen-Angerer, T Kasper, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Developpement Et Sante : Revue De Perfectionnement Medical Et Sanitaire En Pays Tropical|January 1, 1989
[At the Savar center, primary health care (PHC) evolves with the health conditions]P Chirac
Transactions of the Royal Society of Tropical Medicine and Hygiene|July 31, 2003
Translating the essential drugs concept into the context of the year 2000P Chirac
The International Journal of Risk & Safety in Medicine|March 21, 2013
Ethics in the pharmaceutical industry: acceptance of responsibility or a facet of marketing?P Chirac
Lancet (London, England)|April 17, 2001
Updating the WHO essential drugs listP Chirac, R Laing
Lancet (London, England)|October 6, 1998
Intellectual property protection and pharmaceuticalsP Chirac, M Kaddar
Social Science & Medicine (1982)|June 1, 1993
Drug marketing in French-speaking African countriesP Chirac, A Pikon, Y Poinsignon, et al.
JAMA|February 3, 1999
Access to essential drugs in poor countries: a lost battle?B Pécoul, P Chirac, P Trouiller, et al.
Lancet (London, England)|January 6, 2001
Access to fluconazole in less-developed countriesC Perez-Casas, P Chirac, D Berman, et al.
Lancet (London, England)|September 12, 2000
AIDS: patent rights versus patient's rightsP Chirac, T von Schoen-Angerer, T Kasper, et al.
Pageof 1